Monthly Updates

Monthly Progress Notes

A month by month record of what Mammologix has delivered, what is underway, and what is planned. Written for the clients and readers who want to follow the work rather than hear about it once a year.

Last Reviewed: August 25, 2026

  1. MammoComply Alert: FDA Certificate Delivery Is Changing, Effective Today

    Notice

    FDA Certificate Delivery Is Changing, Effective Today

    Starting today, September 14, 2026, the FDA is transitioning MQSA certificate and letter delivery away from postal mail and onto a new online system, the MQSA Facility Portal. Full implementation completes October 22, 2026.

    As your Fulfillment Partner, our support team works diligently to track FDA and MQSA program changes like this as part of our MammoComply service, so you don't have to catch it on your own or find out about it at inspection.

    We've prepared a complete advisory covering exactly what's changing, who is affected, and the specific steps your facility should take before the transition completes, including verifying your FDA contacts and updating your download and display procedure.

    Be sure to share this with the Accreditation Contact, the Most Responsible Individual, and the Inspection Contact. You may also want to share it with your Practice Administrator, Quality Assurance Manager, Lead Interpreting Physician, or anyone else involved in the compliance process at your location.

    Read the full advisory here, including 8 things your facility should be doing now

    This is the kind of regulatory tracking and translation we handle for our client facilities every day. If you have questions about how this applies to your facility, or want help walking through the checklist, reach out to us anytime.

    Team Mammologix

    1-800-739-6919

    Mammologix.com

  2. Mammologix August 2026 Update | New Resources, Tools & Labor Day Hours

    Warm greetings from Mammologix as August draws to a close and we prepare to welcome September.

    We hope you and your team have enjoyed a wonderful summer, and we appreciate the opportunity to continue supporting your breast imaging program.

    Notice

    Labor Day Office Hours

    In observance of Labor Day, Mammologix will be closed Monday, September 7, and our regular office hours will resume on Tuesday, September 8.

    Should you have an immediate need while our office is closed, please call 1-800-739-6919 and ask for the Administrator on Call. We will be happy to assist you.

    From all of us at Mammologix, we wish you, your team, and your families a safe and enjoyable Labor Day weekend.

    Completed

    Introducing Monthly Progress Notes

    We are pleased to introduce a new home for our Monthly Progress Notes.

    Each month, we provide our clients with an update on what Mammologix is delivering, what is currently underway, what we are planning for the months ahead, and other work and developments we believe you may want to follow.

    Beginning with this new format, these updates will also be available on our website so you can easily return to them whenever needed.

    Visit Mammologix.com and look for Monthly Progress Notes under Resources in the website footer.

    We hope this becomes a useful way to stay connected with the work taking place behind the scenes on your behalf.

    Underway

    Mammologix's KnowledgeHub Is Moving

    Another exciting change is coming during September.

    The content you have come to know through the KnowledgeHub is moving directly into Mammologix.com/Resources, where it will become part of our growing Knowledge Hub.

    All of your favorite articles, and many new resources, will be brought together in one place alongside our expanding knowledge areas:

    MammoTrack • MammoCommunicate • MammoNavigate • MammoComply • MammoLibrary • MammoToolbox

    Our goal is to make it easier for breast imaging professionals to find practical information, tools, research, operational guidance, and compliance resources without having to search across multiple locations.

    Visit Mammologix.com/Resources and explore the Knowledge Hub. Be on the lookout throughout September as even more content makes its way to its new home.

    Completed

    Featured in MammoToolbox: Downstream Revenue Estimator

    Have you ever wondered how much economic impact your breast imaging program creates beyond the mammogram itself?

    Breast imaging is often viewed primarily in terms of the examinations performed within the department. But screening can begin a much broader pathway involving diagnostic imaging, biopsy, cancer detection, treatment, and other downstream services throughout the healthcare organization.

    The Mammologix Downstream Revenue Estimator was created to help breast imaging leaders explore that bigger picture.

    The estimator models a mammography program across three distinct components (the screening base, diagnostic referral base, and downstream cascade) and allows you to replace the model's defaults with information specific to your own practice.

    Using published benchmarks, reimbursement information, peer-reviewed literature, and documented assumptions, the calculator provides an interactive way to explore the potential economic contribution generated by your breast imaging program.

    Just as importantly, the methodology is transparent. The formulas, assumptions, defaults, methodology notes, and validation work behind the estimator are available for review.

    For breast imaging leaders preparing for conversations with administration, finance, or organizational leadership, it can provide an entirely different perspective on the value their program contributes across the larger healthcare enterprise.

    Explore the Downstream Revenue Estimator in MammoToolbox.

    Planned

    Coming This Fall: Complimentary PEMAT Review for Client Patient Letters

    Clear communication is an essential part of the patient experience, particularly when patients are receiving information about their mammography results and what they may need to do next.

    This fall, Mammologix will begin providing each of our clients with a complimentary review of their patient letters using the AHRQ Patient Education Materials Assessment Tool, or PEMAT, at no additional charge.

    Developed by the Agency for Healthcare Research and Quality (AHRQ), the PEMAT provides a structured method for assessing two important characteristics of patient education materials:

    Understandability: how effectively patients of different backgrounds and health literacy levels can process and explain the material's key messages.

    Actionability: how effectively patients can identify what they should do based on the information provided.

    Our courtesy report will give your facility an additional perspective on how its patient letters perform using this established assessment framework. Where opportunities are identified, our team will also be available to discuss the findings and assist with potential improvements you may wish to consider.

    The goal is simple: to help ensure that the information reaching your patients is not only delivered reliably, but is as understandable and actionable as possible.

    You can also explore the Mammologix PEMAT Scoring Instrument and additional information about the methodology in the MammoToolbox.

    Thank You for Allowing Us to Serve You

    As always, thank you for the opportunity to support you, your team, and the patients you serve.

    For more than 30 years, our work at Mammologix has grown from listening to breast imaging professionals, understanding the challenges they face, and finding practical ways to make their work more visible, dependable, and manageable.

    We are grateful to have you as part of the Mammologix community.

    If there is ever anything we can do to assist your facility, answer a question, or help you explore an opportunity for improvement, please reach out. We are always glad to help.

    The Mammologix Team

    1-800-739-6919

    Mammologix.com

Disclaimer

The content, articles, calculators, tools, estimates, projections, derived data, reports, and other materials provided by Mammologix, LLC, powered by I/O Trak, Inc. (“Mammologix”) are provided for informational and educational purposes only.

The information and outputs provided by Mammologix are not intended to serve as, and should not be relied upon as, medical advice, diagnosis, treatment, clinical guidance, financial advice, investment advice, tax advice, legal advice, accounting advice, or any other professional advice.

Information provided by Mammologix may relate to breast health, mammography, imaging, screening, diagnostics, clinical outcomes, healthcare topics, financial calculations, estimates, projections, or other decision-support information. However, such information should not be used to make personal medical, clinical, financial, investment, business, insurance, legal, or other important decisions without consulting an appropriate qualified professional.

Always seek the advice of a licensed physician, radiologist, healthcare provider, financial advisor, accountant, attorney, or other qualified professional with any questions you may have about a medical condition, screening recommendation, imaging result, treatment option, financial matter, or other professional decision. Never disregard professional medical, financial, legal, or other advice, or delay seeking such advice, because of something you have read, calculated, or received through Mammologix.

Any calculators, formulas, estimates, projections, derived medical outcome data, financial calculations, or other tool-generated outputs are provided as estimates only. Results may be affected by user-entered information, assumptions, formula limitations, incomplete or inaccurate data, rounding, software errors, third-party data, changing medical guidelines, changing financial conditions, changes in law or regulation, or other factors. Mammologix does not represent, warrant, or guarantee that any calculation, output, article, estimate, projection, or derived data is accurate, complete, current, reliable, suitable, or appropriate for any particular purpose.

For medical or health-related content and calculators, Mammologix does not provide medical advice, diagnosis, treatment recommendations, diagnostic interpretation, or patient-specific clinical decision-making. Mammologix content and tools are not a substitute for an in-person evaluation, professional medical consultation, diagnostic interpretation, or individualized care from a licensed healthcare provider. In the event of a medical emergency, contact emergency services or a qualified healthcare provider immediately.

For financial, business, tax, investment, or accounting-related calculators or content, Mammologix does not provide financial, investment, tax, legal, accounting, or business advice. Any outputs are estimates only, and actual results may vary materially based on personal circumstances, market conditions, taxes, fees, interest rates, inflation, risk tolerance, regulatory changes, and other factors.

Use of Mammologix content, articles, calculators, tools, and outputs is at your own risk. You are solely responsible for reviewing, verifying, and interpreting any information or results provided and for obtaining appropriate professional advice before relying on or acting upon such information.

Mammologix assumes no liability for any injury, loss, claim, damage, or expense arising from or related to the use of, reliance on, or inability to use any Mammologix content, article, calculator, tool, estimate, projection, derived data, report, or website material. To the fullest extent permitted by law, Mammologix, its owners, officers, employees, contractors, affiliates, licensors, service providers, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, punitive, financial, medical, clinical, business, or other damages arising out of or relating to the use of Mammologix materials or outputs.

The information provided by Mammologix does not establish a doctor-patient, provider-patient, radiologist-patient, financial advisor-client, attorney-client, accountant-client, fiduciary, or other professional relationship.

AI Content Disclosure

Some Mammologix content, calculations, summaries, tools, or outputs may be created, edited, generated, or assisted by artificial intelligence tools or automated systems. While Mammologix may review content for accuracy and relevance, AI-assisted or automated materials may contain errors, omissions, inaccuracies, outdated information, or outputs that are incomplete or inappropriate for a particular user, patient, circumstance, or purpose.

Users should independently verify all AI-assisted content, calculator outputs, and automated results with appropriate qualified professionals before relying on them.

Didn't find what you were looking for?

Our team has supported breast imaging centers since 1995. If it's not here, we probably know the answer.

Ask a Question →